Lab Information
Nadine Kronfli (MD)
Junior ScientistCentre for Outcomes Research and Evaluation
Department of Medicine (McGill)
Research Profile
Keywords
HIV • hepatitis C • vulnerable populations • evidence-based care • evidence-based policiesResearch Interests
My research focuses on designing, deploying, and evaluating evidence-based models of care that aim to increase engagement along the HIV and hepatitis C virus care cascades for vulnerable populations, with a particular focus on people in prison, women, and asylum seekers. The ultimate goal of my research is to support the development of evidence-based policies to improve population health with an emphasis on controlling and eliminating HIV and hepatitis C.Team Members
| Name | Position |
|---|
Latest Publications
- Levinsson, A., Zolopa, C., Vakili, F., Udhesister, S., Kronfli, N., Maheu-Giroux, M., Bruneau, J., Valerio, H., Bajis, S., Read, P., Martró, E., Boucher, L., Morris, L., Grebely, J., Artenie, A., Stone, J., Vickerman, P. & Larney, S. (2024). Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis. EClinicalMedicine, vol. 72, p. 102596.
- Kwon, J. A., Bretaña, N. A., Kronfli, N., Dussault, C., Grant, L., Galouzis, J., Hoey, W., Blogg, J., Lloyd, A. R. & Gray, R. T. (2024). Preparing correctional settings for the next pandemic: a modeling study of COVID-19 outbreaks in two high-income countries. Frontiers in public health, vol. 12, p. 1279572.
- Walker, S. J., Shrestha, L. B., Lloyd, A. R., Dawson, O., Sheehan, Y., Sheehan, J., Maduka, N. B. C., Cabezas, J., Akiyama, M. J., Kronfli, N. & INHSU Prisons (2024). Barriers and advocacy needs for hepatitis C services in prisons: Informing the prisons hepatitis C advocacy toolkit. The International journal on drug policy, vol. 126, p. 104386.
- Arora, A. K., Vicente, S., Engler, K., Lessard, D., Huerta, E., Ishak, J., Routy, J.-P., Klein, M., Kronfli, N., Cox, J., Lemire, B., de Pokomandy, A., Del Balso, L., Sebastiani, G., Vedel, I., Quesnel-Vallée, A., ASAP Migrant Advisory Committee & Lebouché, B. (2024). Impact of social determinants of health on time to antiretroviral therapy initiation and HIV viral undetectability for migrants enrolled in a multidisciplinary HIV clinic with rapid, free, and onsite B/F/TAF: 'The ASAP study'. HIV medicine.
- Mambro, A., Afshar, A., Leone, F., Dussault, C., Stoové, M., Savulescu, J., Rich, J. D., Rowan, D. H., Sheehan, J. & Kronfli, N. (2023). Reimbursing incarcerated individuals for participation in research: A scoping review. The International journal on drug policy, vol. 123, p. 104283.
- Cinque, F., Saeed, S., Kablawi, D., Ramos Ballesteros, L., Elgretli, W., Moodie, E. E. M., Price, C., Monteith, K., Cooper, C., Walmsley, S. L., Pick, N., Murray, M. C. M., Cox, J., Kronfli, N., Costiniuk, C. T., de Pokomandy, A., Routy, J.-P., Lebouché, B., Klein, M. B. & Sebastiani, G. (2023). Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort. BMJ open, vol. 13, p. e076547.
- Snell, G., Marshall, A. D., van Gennip, J., Bonn, M., Butler-McPhee, J., Cooper, C. L., Kronfli, N., Williams, S., Bruneau, J., Feld, J. J., Janjua, N. Z., Klein, M., Cunningham, N., Grebely, J. & Bartlett, S. R. (2023). Public reimbursement policies in Canada for direct-acting antiviral treatment of hepatitis C virus infection: A descriptive study. Canadian liver journal, vol. 6, p. 190-200.
- Stannah, J., Soni, N., Lam, J. K. S., Giguère, K., Mitchell, K. M., Kronfli, N., Larmarange, J., Moh, R., Nouaman, M., Kouamé, G. M., Boily, M.-C. & Maheu-Giroux, M. (2023). Trends in HIV testing, the treatment cascade, and HIV incidence among men who have sex with men in Africa: a systematic review and meta-analysis. The lancet. HIV, vol. 10, p. e528-e542.
- Lanièce Delaunay, C., Klein, M. B., Godin, A., Cox, J., Kronfli, N., Lebouché, B., Doyle, C. & Maheu-Giroux, M. (2023). Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study. The International journal on drug policy, vol. 116, p. 104026.
- Passos-Castilho, A. M., Udhesister, S. T. P., Fontaine, G., Jeong, D., Dickie, M., Lund, C., Russell, R. & Kronfli, N. (2023). The 11th Canadian Symposium on Hepatitis C Virus: 'Getting back on track towards hepatitis C elimination'. Canadian liver journal, vol. 6, p. 56-69.
See also
